• Latest Posts

Beacon Therapeutics launches with $120M to develop gene therapies for retinal diseases

Syncona to acquire Applied Genetic Technologies Corporation

Forcefield Therapeutics Launched to Treat Heart Attacks with Protein Drugs

UK Biotech Closes €50M Series A for GPCR Drug Discovery

Immuno-oncology Biotech Raises €31M to Progress T-Cell Boosting Therapy

€40M in Series C for a British Biotech Treating Blindness with Gene Therapy


18 of the Best European VCs for Biotech in 2016

CAR-T Startup Gets €51M from Top&New Investors

British Startup Raises Millions to Become the Illumina for Epigenetics

Oxford’s Nightstar Gene Therapy for Blindness in Men Shines with $35M Fundraiser

The Top 15 European Biotech VCs